Regulation of the Immune Response to α-Gal and Vector-borne Diseases

Trends in Parasitology

Volumn 31, Issue 10, 2015, Pages 470-476

  Cabezas Cruz, Alejandro ^a   Mateos Hernández, Lourdes ^b   Pérez Cruz, Magdiel ^a   Valdés, James J ^c   Mera, Isabel G Fernández de ^b   Villar, Margarita ^b   de la Fuente, José ^b,d  

^a UNIV LILLE   (France)

^b CSIC   (Spain)

^c INSTITUTE OF PARASITOLOGY   (Czech Republic)

^d OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Alpha gal; Malaria; Tick; Vaccine; Vector borne diseases

Indexed keywords

GALACTOSE; ARTHROPOD PROTEIN; IMMUNOGLOBULIN E;

AMBLYOMMA AMERICANUM; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; B LYMPHOCYTE; CYTOKINE RESPONSE; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOREGULATION; INTESTINE FLORA; MALARIA FALCIPARUM; NONHUMAN; PARASITE VECTOR; PLASMODIUM; PLASMODIUM FALCIPARUM; REVIEW; TH2 CELL; TICK BITE; ANIMAL; DISEASE CARRIER; HOST PARASITE INTERACTION; HYPERSENSITIVITY; IMMUNOLOGY;

ANIMALS; ARTHROPOD PROTEINS; ARTHROPOD VECTORS; DISEASE VECTORS; HOST-PARASITE INTERACTIONS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; TH2 CELLS;

EID: 84943231194     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.06.016     Document Type: Review

References (52)

1. Jones K.E., et al. Global trends in emerging infectious diseases. Nature 2008, 451:990-994.
2. Moreno-Cid J.A., et al. Characterization of Aedes albopictus akirin for the control of mosquito and sand fly infestations. Vaccine 2011, 29:77-82.
3. de la Fuente J., Kocan K.M. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Rev. Vaccines 2003, 2:583-593.
4. Kishore K., et al. Vector control in leishmaniasis. Indian J. Med. Res. 2006, 123:467-472.
5. Sperança M.A., Capurro M.L. Perspectives in the control of infectious diseases by transgenic mosquitoes in the post-genomic era: a review. Mem. Inst. Oswaldo Cruz 2007, 102:425-433.
6. Gortazar C., et al. Crossing the interspecies barrier: opening the door to zoonotic pathogens. PLoS. Pathog. 2014, 10:e1004129.
7. Estrada-Peña A., et al. Effects of environmental change on zoonotic disease risk: an ecological primer. Trends Parasitol. 2014, 30:205-214.
8. Pruneau L., et al. Understanding Anaplasmataceae pathogenesis using "Omics" approaches. Front. Cell. Infect. Microbiol. 2010, 4:86.
9. de la Fuente J., Merino O. Vaccinomics, the new road to tick vaccines. Vaccine 2013, 31:5923-5929.
10. Cabezas-Cruz A., et al. Cancer research meets tick vectors for infections diseases. Lancet Infect. Dis. 2014, 10:916-917.
11. Wen L., et al. Delayed anaphylaxis to red meat associated with specific IgE antibodies to galactose. Allergy Asthma Immunol. Res. 2015, 7:92-94.
12. Commins S.P., et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J. Allergy Clin. Immunol. 2009, 123:426-433.
13. Commins S.P., Platts-Mills T.A. Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal). Curr. Allergy Asthma Rep. 2013, 13:72-77.
14. Ghahramani G.K., Temprano J. Tick bite-related meat allergy as a cause of chronic urticaria, angioedema, and anaphylaxis in endemic areas. Int. J. Dermatol. 2015, 54:e64-e65.
15. Preston S.G., et al. Novel immunomodulators from hard ticks selectively reprogramme human dendritic cell responses. PLoS Pathog. 2013, 9:e1003450.
16. Conrad D.H., et al. Regulation of the IgE response. F1000. Biol. Rep. 2010, 2:1-4.
17. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol. Cell Biol. 2005, 83:674-686.
18. Chung C.H., et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N. Engl. J. Med. 2008, 358:1109-1117.
19. Jafarzadeh A., et al. Salivary IgA and IgE levels in healthy subjects: relation to age and gender. Braz. Oral Res. 2010, 24:21-27.
20. Kolmannskog S., et al. The excretion of IgE with feces from healthy individuals and from others with allergy and diseases affecting the intestinal tract. Int. Arch. Allergy Appl. Immunol. 1986, 79:357-364.
21. Yilmaz B., et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell 2014, 159:1277-1289.
22. Kazimírová M., Štibrániová I. Tick salivary compounds: their role in modulation of host defenses and pathogen transmission. Front. Cell. Infect. Microbiol. 2013, 3:43.
23. Commins S.P., et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. J. Allergy Clin. Immunol. 2011, 127:1286-1293.
24. Steinke J.W., et al. The alpha-gal story: Lessons learned from connecting the dots. J. Allergy Clin. Immunol. 2015, 135:589-596.
25. van Nunen S. Tick-induced allergies: mammalian meat allergy, tick anaphylaxis and their significance. Asia Pac. Allergy 2015, 5:3-16.
26. Commins S.P., Platts-Mills T.A. Tick bites and red meat allergy. Curr. Opin. Allergy Clin. Immunol. 2013, 13:354-359.
27. Lammerts van Bueren J.J., et al. Anti-galactose-α-1,3- galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains. Nat. Biotechnol. 2011, 29:574-576.
28. Platts-Mills T.A., et al. Anaphylaxis to the carbohydrate side chain alpha-gal. Immunol. Allergy Clin. North Am. 2015, 35:247-260.
29. Hamsten C., et al. Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy. Allergy 2013, 68:549-552.
30. Andreotti R., et al. Assessment of bacterial diversity in the cattle tick Rhipicephalus (Boophilus) microplus through tag-encoded pyrosequencing. BMC Microbiol. 2011, 11:6.
31. Wikel S. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. Front. Microbiol. 2013, 4:337.
32. Thangamani S., et al. Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS ONE 2010, 5:e12137.
33. Jones L.D., Nuttall P.A. The effect of host resistance to tick infestation on the transmission of Thogoto virus by ticks. J. Gen. Virol. 1990, 71:1039-1043.
34. Bell J.F., et al. Resistance to tick-borne Francisella tularensis by tick-sensitized rabbits: allergic klendusity. Am. J. Trop. Med. Hyg. 1979, 28:876-880.
35. Nazario S., et al. Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am. J. Trop. Med. Hyg. 1998, 58:780-785.
36. Stavnezer J., et al. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
37. Basu M., Basu S. Enzymatic synthesis of blood group related pentaglycosyl ceramide by an α-galactosyltransferase. J. Biol. Chem. 1973, 248:1700-1706.
38. Galili U. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology 2013, 140:1-11.
39. de la Fuente J., et al. Overview: ticks as vectors of pathogens that cause disease in humans and animals. Front. Biosci. 2008, 13:6938-6946.
40. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
41. Chappuis F., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 2007, 5:873-882.
42. Platts-Mills T.A., Commins S.P. Emerging antigens involved in allergic responses. Curr. Opin. Immunol. 2013, 25:769-774.
43. Caponetto P., et al. Gelatin-containing sweets can elicit anaphylaxis in a patient with sensitization to galactose-α-1,3-galactose. J. Allergy Clin. Immunol. 2013, 1:302-303.
44. Jappe U. Anaphylaxis caused by hidden food allergens: the α-Gal syndrome. Allergologie 2014, 37:S265-S274.
45. Hamsten C., et al. Red meat allergy in Sweden: association with tick sensitization and B-negative blood groups. J. Allergy Clin. Immunol. 2013, 132:1431-1434.
46. Jacquenet S., et al. Mammalian meat-induced anaphylaxis: clinical relevance of anti-galactose-alpha-1,3-galactose IgE confirmed by means of skin tests to cetuximab. J. Allergy Clin. Immunol. 2009, 124:603-605.
47. Renaudin J., et al. Interest of specific IgE measurement for galactose-alpha-1,3-galactose in unexplained urticaria and angioedema, predominantly nocturnal: about 6 cases. J. Allergy Clin. Immunol. 2012, 129:AB177.
48. Morisset M., et al. Anaphylaxis to pork kidney is related to IgE antibodies specific for galactose-alpha-1,3-galactose. Allergy 2012, 67:699-704.
49. Nuñez R. Delayed mammalian meat-induced anaphylaxis due to galactose-α-1,3-galactose in 5 European patients. J. Allergy Clin. Immunol. 2011, 128:1122-1124.
50. Michel S., et al. Skin prick test and basophil reactivity to cetuximab in patients with IgE to alpha-gal and allergy to red meat. Allergy 2014, 69:403-405.
51. Lee J.H., et al. Delayed mammalian meat-induced anaphylaxis confirmed by skin test to cetuximab. J. Dermatol. 2013, 40:577-578.
52. Sekiya K., et al. Delayed anaphylactic reaction to mammalian meat. J. Invest. Allergol. Clin. Immunol. 2012, 22:446-447.